Existing users Log In New users Sign up

The Bidirectional Relationship between Metabolism and Immune Responses

DISCOVERIES (ISSN 2359-7232), 2013, October-December

Raval FM, Nikolajczyk BS. The Bidirectional Relationship between Metabolism and Immune Responses. Discoveries 2013, Oct-Dec; 1(1): e6.
DOI: 10.15190/d.2013.6

Submitted: November 25, 2013; Revised: December 30, 2013; Accepted: December 30, 2013; Published: December 31, 2013; 

GO BACK to 2013, Oct-Dec issue

The Bidirectional Relationship between Metabolism and Immune Responses

and *

Boston University School of Medicine, Department of Microbiology, Boston, MA, USA

*Correspondence to: Prof. Barbara S. Nikolajczyk, Department of Microbiology, Boston University School of Medicine; Phone: 617-638-7019; Fax: 617-638-4286; Email: bnikol@bu.edu


Immunometabolism investigates the multiple links between the immune system and metabolism. One main focus of immunometabolism investigates how obesity impacts the immune system and pro-inflammatory immune cell function, leading to metabolic diseases, including type 2 diabetes (T2D). The second focus stresses the metabolic changes that dictate immune cell activation. Several groups have studied these two arms of the field individually, but work that integrates both topics will be required to develop an accurate understanding of how immune cells and metabolic pathways collaborate in obesity and obesity-associated T2D. Investigations of the relationships among obesity-induced changes in the nutritional environment, immune cell activation, and immune cell metabolism may lead to novel and efficacious therapies for obesity-associated disorders such as insulin resistance (IR) and T2D. This review outlines recent insights into two related processes: 1. the role that energy utilization plays in immune responses and 2. the immune cell functions that drive obesity and T2D. Herein, we begin to consider how shifts in available fuel sources in obesity and T2D impact the immune response to both pathogens and chronic over nutrition.

Access full text of the manuscript here:  


This work was supported by NIH grant R56 DK096525 (to BSN).


1. Nikolajczyk, B.S., Jagannathan-Bogdan, M., Denis, G.V. The outliers become a stampede as immuno-metabolism reaches a tipping point. Immunol. Rev. 2012; 249: 253-275.
2. DeFuria, J. et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. U.S.A. 2013; 110: 5133–5138.
3. Jagannathan-Bogdan, M. et al. Elevated pro-inflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol. 2011; 186: 1162–1172.
4. Olefsky, J. M. & Glass, C. K. Macrophages, Inflammation, and Insulin Resistance. Annu. Rev. Physiol. 2010; 72: 219-46.
5. Da Young Oh, Morinaga, H., Talukdar, S., Bae, E. J. & Olefsky, J. M. Increased Macrophage Migration Into Adipose Tissue in Obese Mice. Diabetes 2012; 61: 346-354.
6. Orr, J. S. et al. Obesity Alters Adipose Tissue Macrophage Iron Content and Tissue Iron Distribution. Diabetes 2013.
7. Shu, C. J., Christophe Benoist & Diane Mathis. The immune system’s involvement in obesity-driven type 2 diabetes. Semin Immunol. 2013.
8. Jagannathan, M. et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010; 53: 1461–1471.
9. Winer, D. A. et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011; 17: 610–617.
10. Ioan-Facsinay, A. et al. Adipocyte-derived lipids modulate CD4+ T-cell function. Eur. J. Immunol. 2013; 43: 1578-1587.
11. Murano, I. et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J. Lipid Res. 2008; 49: 1562–1568.
12. Wu, H. et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115: 1029–1038.
13. Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature Medicine 2009; 15: 914-920.
14. Yang, H. et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 2010; 185: 1836–1845.
15. O'Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010; 327; 1098–1102.
16. Goossens, G. H. et al. Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol. Immunol. 2012; 50: 142–149.
17. Haskell, B. D., Flurkey, K., Duffy, T. M., Sargent, E. E. & Leiter, E. H. The Diabetes-Prone NZO/HlLt Strain. I. Immunophenotypic Comparison to the Related NZB/BlNJ and NZW/LacJ Strains. Laboratory Investigation 2002; 82: 833–842.
18. Gotoh, K. et al. A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and Liver. Diabetes 2012; 61: 1994-2003.
19. Nishimura, S. et al. Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation. Cell Metab. 2013; 18: 759-766.
20. Kuniko Takagi et al. Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nature Communication 2013.
21. Jagannathan, M. et al. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J. Immunol. 2009; 183: 7461–7470.
22. Fox, C. J., Hammerman, P. S. & Thompson, C. B. Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 2005; 5: 844–852.
23. Pearce, E. L. & Pearce, E. J. Metabolic Pathways in Immune Cell Activation and Quiescence. Immunity 2013; 38: 633-643.
24. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029–1033.
25. Hammerman, P. S., Fox, C. J. & Thompson, C. B. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem. Sci. 2004; 29: 586–592.
26. SanshiroTateya, Kim, F. & Tamori, A. Y. Recent advances in obesity-induced inflammation and insulin resistance. Frontiers in Endrocrin. 2013; 4: 1-14.
27. Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009; 460: 103–107.
28. Michalek, R. D. et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets. J Immunol. 2011; 186: 3299-3303.
29. Hardie, L. A. J. O. D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature Rev. 2013; 493: 346-355 (2013).
30. Gauthier, M.-S. et al. Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem. Biophys. Res. Commun. 2011; 404: 382–387.
31. Frauwirth, K. A. & Thompson, C. B. Regulation of T Lymphocyte Metabolism. J Immunol. 2004; 172: 4661-4665.
32. Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010; 115: 4742–4749.
33. Rodríguez-Prados, J.-C. et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 2010; 185: 605–614.
34. Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1ß through HIF-1a. Nature 2013; 496: 238–242.
35. Doughty, C. A. et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006; 107: 4458-4465.
36. Dufort, F. J. et al. Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. The Journal of Immunology 2007; 179: 4953–4957.
37. Woodland, R. T. et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008; 111: 750–760.
38. Shi, H. et al. TLR4 links innate immunity and fatty acid–induced insulin resistance. Journal of Clin. Invest. 2006; 116: 3015-3025.
39. Weigert, C. et al. Mechanisms of Signal Transduction:Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-?B. J. Biol. Chem. 2004; 279: 23942-23952.
40. Figueras, M., Olivan, M., Busquets, S., López-Soriano, F. J. & Argilés, J. M. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity (Silver Spring) 2011; 19: 362–369.
41. Yazdani-Biuki, B. et al. Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab. Eur. J. Clin. Invest. 2004 ; 34 : 641–642.
42. Larsen, C. M. et al. Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus. N Engl J Med 2007; 356: 1517–1526.
43. Goldfine, A. B. et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 2008; 1: 36–43.
44. Koska, J. et al. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 2009; 52: 385–393.
45. Sakamoto, G. R. E. R. P. K. Molecular mechanism of action of metformin: old or new insights? Diabetologia 2013; 56: 1898-1906.
46. Leung, J. et al. Possible Association between Obesity and Clostridium difficile Infection. Emerging Infect. Dis. 2013; 19: 1791–1798.

GO BACK to 2013, Oct-Dec issue

Email Email us at info@discoveriesjournals.org if you have any questions.

News & Events Latest news from our journals.

  • 2021, January| 2021 AWARDS!

    2021 DISCOVERIES AWARDS! Discoveries will offer a $1000 award and at least five $400 awards in Jan 2022, for the most cited (2021 ISI Citations) and visible (Altmetric Score) articles published in 2018-2021.

  • 2020, November| Discoveries on Twitter!

    You can now follow the latest Discoveries news and updates on Twitter! (@DiscoveriesNews) 

  • 2020, August| For Authors!

    Due to a high volume of article submissions, our peer-review process takes more than usual. The pre-screening decision is released in 1-2 days, while the peer-review process lasts between 10 and 20 days.  

  • 2020, April | For Authors!

    WE DO NOT TOLERATE ANY MISCONDUCT! Please be aware that we are testing all received articles with specialized software for PLAGIARISM and WE WILL TAKE MEASURES if your article is already published or in consideration for publication by other journals! This may result in serious professional consequences for the authors. The latest striking case is the following article which is already published and was re-submitted here.  

  • 2020, April | For Authors!

    We are happy to let you know that all articles published in Discoveries are now on PubMedCentral (PMC). New accepted articles will be included in PMC and PubMed within 1-2 weeks after their publication.

  • 2020, January | For Authors!

    Starting in January 2020, Discoveries will also consider articles submitted by Discoveries' Editorial Board members. However, only a small number of such articles (maximum 4 articles/year) will be considered for publication after the peer-review process, and the authors who are also our editors will be clearly disclosed. 

  • 2019, September | Indexed by PMC

    Discoveries is now indexed by PubMedCentral and Pubmed. The agreement with US National Library of Medicine was signed on September 10, 2019. Our next step is ISI Web of Science indexing. NOTE: previously published articles will be included on PubMed in early 2020.

  • 2019, September | PubMed inclusion!

    We are happy to let you know that Discoveries successfuly passed the last step (Technical Review) required for PubMedCentral and PubMed inclusion!

  • 2019, June | PubMed inclusion News!

    We are happy to receive positive comments from PMC/NLM-NIH regarding Discoveries' last step (Technical Review) required for PubMedCentral and PubMed inclusion. We will let you know once whole indexing process is completed. 

  • 2018-2019 | For Authors!

    From now on and for at least 1 year, we will only accept articles from authors that are NOT members of Discoveries' Editorial Board. All articles submitted by our editors will be immediately rejected until further notice. 

  • 2018 | PubMed inclusion News!

    Discoveries successfully passed the Scientific Quality Review by NLM-NIH for PubMedCentral and PubMed indexing. This is the first and the most important step towards PubMedCentral and PubMed indexing! The second (last) step is the Technical Review.

  • April 2016 | Faster Peer-Review

    Starting on April 13th, all articles selected for a peer-review will receive the post peer-review decision within 10 days. The initial pre-screening time will remain the same (48h from the submission of the manuscript). This decision will significantly accelerate the publication, with no effect on the quality of the peer-review process.

  • February 2016 | Manuscript submission

    Discoveries is commited to excellence, quality and high editorial standards. We are receiving an increasing number of manuscripts for which the identity of the authors/corresponding author can't be verified. Please NOTE that ALL these articles were and will be immediately REJECTED. Indicating an institutional email address is the easiest way to overcome this problem! Moreover, we do not accept any pressure on our editorial board to accept a manuscript. This results in a prompt rejection of the article.

    Editorial Policies
  • January 2016 |Discoveries-AIM

    After reaching all proposed milestones until now (including being indexed by Google Scholar in 2014), Discoveries' next Aim is PubMed indexing of all its articles (already published and upcoming). There will be no charge for the submission or publication of articles in Discoveries before PubMed indexing.

  • August 2015 | Discoveries - on PubMed

    We are happy to announce that our first Discoveries articles were included in PMC and PubMed. More articles (submitted by NIH funded articles) are now processed for being included.

    Discoveries articles now on PubMed
  • April 2015 | Special Issue

    DISCOVERIES publish the SPECIAL ISSUE entitled "INFLAMMATION BETWEEN DEFENSE AND DISEASE: Impact on Tissue Repair and Chronic Sickness".

    Special Issue on "Inflammation"
  • 2015 | Ischemia Collection

    DISCOVERIES launched a call for papers for a Collection of Articles with focus on "ISCHEMIA". If you are interested to submit a manuscript, please contact us at info@discoveriesjournals.org

  • October 2014 | Special Issue

    DISCOVERIES launched a call for papers, for the SPECIAL ISSUE entitled "INFLAMMATION BETWEEN DEFENSE AND DISEASE: Impact on Tissue Repair and Chronic Sickness".

  • September 2014 | Special Issue

    DISCOVERIES just publish the SPECIAL ISSUE entitled "CELL SECRETION & MEMBRANE FUSION" in September 2014. Initially scheduled for publication between October 2014-March 2015, this issue was successfully published earlier than scheduled. 

    Special Issue
  • April 2014 | Indexed by Google Scholar

    All our published articles are now indexed by Google Scholar! Current citations for each individual article published in either Discoveries or Discoveries Reports are also shown. First citations to Discoveries articles are included! Search for the article's title or the authors:

    Google Scholar Search

  • July 2013 | Manuscript Submission

    Submit your manuscript FREE, FAST and EASY ! (in less than 1 minute)
    There are NO fees for the manuscript submission or publishing of the accepted manuscripts.

    Read more

  • July 2013 | DISCOVERIES

    We are now ACCEPTING MANUSCRIPTS for publishing in DISCOVERIES. We aim to publish a small number of high impact experimental articles & reviews (around 40/year) to maintain a high impact factor. Domains of interest: all areas related to Medicine, Biology and Chemistry ...

    Read more


    We are now ACCEPTING MANUSCRIPTS for DISCOVERIES REPORTS, publishing inovative and important research findings from all areas related to Medicine, Biology and Chemistry. We are also accepting experimental articles that validate/invalidate highly used reagents in current publications (ex. antibodies) and selected articles presenting negative data with impact and of wide scientific interest ...

    Read more

Member Login
Free Registration Click here to sign up
Copyright © 2013 Applied Systems. All Rights Reserved.